Citric/citrate buffer: An effective antiglycolytic agent

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 10, 2013, Pages 1943-1949

  Del Pino, Isabel García ^a   Constanso, Ignacio ^b   Mourín, Luis Vázquez ^b   Safont, Carmela Barbuzano ^a   Vázquez, Pastora Rodríguez ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

Antiglycolytic additives; Diabetes mellitus; Glucose; Glycolysis; Preanalytical conditions; Preanalytical phase

Indexed keywords

BUFFER; CITRIC ACID; FLUORIDE; GLUCOSE; HEPARIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CENTRIFUGATION; CITRIC ACID ADDITIVE TUBE; COMPARATIVE STUDY; DIAGNOSTIC TEST; FEMALE; FLUORIDE ADDITIVE TUBE; GEL SERUM TUBE; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HEMOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PLASMA HEPARIN TUBE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SCREENING TEST; TUBE;

ADULT; ANTICOAGULANTS; BLOOD CELLS; BLOOD GLUCOSE; BLOOD SPECIMEN COLLECTION; BUFFERS; CENTRIFUGATION; CITRIC ACID; DIABETES, GESTATIONAL; FEMALE; GLYCOLYSIS; HEMOLYSIS; HEPARIN; HUMANS; MALE; MIDDLE AGED; PREGNANCY; SODIUM FLUORIDE;

EID: 84888080913     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0735     Document Type: Article

References (21)

1. Bruns DE, Knowler WC. Stabilization of glucose in blood samples: why it matters [editorial]. Clin Chem 2009;55: 850-2.
2. Stahl M, Jørgensen LG, Hyltoft Petersen P, Brandslund I, De Fine Olivarius N, Borch-Johnsen K. Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001;61: 169-80.
3. Mikesh L, Bruns DE. Stabilization of glucose in blood specimens: mechanism of delay in fluoride inhibition of glycolysis [Letter]. Clin Chem 2008;54: 930-1.
4. Marbach EP, McLean M, Scharn M, Jones T. Sodium iodoacetate as an antiglycolytic agent in blood samples. Clin Chem 1975;21: 1810-2.
5. Narayanan S. The pre-analytic phase: an important component of laboratory medicine. Am J Clin Pathol 2000;113: 429-52. (Pubitemid 30217392)
6. Waring WS, Evans LE, Kirkpatrick CT. Glycolysis inhibitors negatively bias blood glucose measurements: potential impact on the reported prevalence of diabetes mellitus. J Clin Pathol 2007;60: 820-3. (Pubitemid 47056914)
7. Guder WG, Narayanan S, Wisser H, Zawta B. editors, Take a lavender tube! In: Diagnostic samples: from the patient to the laboratory, 4th ed. Weinheim: Wiley-VCH Verlag GmbH&Co, 2009: 36-7.
8. Nakashima K, Takei H, Nasu Y, Andoh Y. D-Mannose as a preservative of glucose in blood samples. Clin Chem 1987;33: 708-10. (Pubitemid 17155703)
9. Chan AY, Ho CS, Chan TY, Swaminathan R. D-Mannose as a preservative of glucose in blood samples. Clin Chem 1992;38: 411-3.
10. Uchida K, Matuse R, Toyoda E, Okuda S, Tomita S. A new method of inhibiting glycolysis in blood samples. Clin Chim Acta 1988;172: 101-8. (Pubitemid 18051970)
11. Gambino R, Piscitelli J, Ackattupathil TA, Theriault JL, Andrin RD, Sanfilippo ML, et al. Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis. Clin Chem 2009;55: 1019-21.
12. World Health Organization. What diagnostic tests should be used to define glycaemic status. In: Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva: WHO, 2006: 29-30.
13. NCCLS. Method comparison and bias estimation using patient samples; Approved guideline, 2nd ed. NCCLS document EP9-A2 [ISBN 1-56238-472-4]. Wayne, PA: NCCLS, 2002.
14. Bartha JL, Cerqueira MJ, González-González NL, Jáñez M, Mozas J, Ramírez O, et al. Diabetes y embarazo. Guía asistencial 2006 (Diabetes and pregnancy. Clinical guidelines 2006). Prog Obstet Ginecol 2007;50: 249-64.
15. Standards of medical care in diabetes - 2010. Diabetes Care 2010;33(Suppl 1):S11-61.
16. Minchinela J, Ricós C, Perich C, Fernández-Calle P, Álvarez V, Domenech M, et al. Biological variation database, and quality specifications for imprecision, bias and total error (desirable and minimum). The 2012 update. Analytical Quality Committee, Spanish Society of Clinical Chemistry and Molecular Pathology (SEQC). Available from: http://www.westgard. com/biodatabase1.htm. Accessed on April 2011.
17. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. [Special Report].Clin Chem 2011;57:e1-47.
18. Mäkinen K. Kokemuksia uudesta glykolyysin estäjästä veren/plasman glukoosimäärityksessä (Experiences of new glicólisis inhibitors in blood plasma determination). Kliin Lab 1992;4: 85-8.
19. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28: 1039-57.
20. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144: 768-73. (Pubitemid 13196587)
21. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82.